Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESRRG | P62508 | 6/20 | 0.72 |
| ▸ | RAB9A | P51151 | 5/20 | 0.62 |
| ▸ | NPC1 | O15118 | 3/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 5/20 | 0.60 |
| ▸ | GAA | P10253 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | MITF | O75030 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | GCGR | P47871 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4274744 | 1.00 | ESRRG (0.72) | ESRRGRAB9ANPC1CYP1A2MAPT | |
| SCHEMBL28471694 | 0.84 | ESRRG (1.00) | ESRRGRAB9ANPC1CYP1A2MAPT | |
| SCHEMBL22925022 | 0.83 | LMNA (0.77) | ESRRGRAB9ANPC1MAPTGAA | |
| SCHEMBL13903557 | 0.81 | MIF (0.76) | ESRRGRAB9ANPC1MAPTGAA | |
| SCHEMBL17290220 | 0.81 | MIF (0.76) | ESRRGRAB9ANPC1MAPTGAA | |
| SCHEMBL24278445 | 0.81 | ESRRG (0.60) | ESRRGRAB9ANPC1MAPTGAA | |
| SCHEMBL16224308 | 0.81 | ESRRG (0.60) | ESRRGRAB9ANPC1MAPTGAA | |
| Hydrochloric Acid SCHEMBL17560765 | 0.79 | ESRRG (0.59) | ESRRGRAB9ANPC1MAPTGAA | |
| SCHEMBL23996030 | 0.78 | ESRRG (0.64) | ESRRGRAB9ANPC1MAPTGAA | |
| SCHEMBL7099953 | 0.78 | KDM4E (0.73) | ESRRGRAB9ANPC1CYP1A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090062358-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | CANO IVAN COLLADO | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062358-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | PPARG, PPARA, PPARD | ESRRG 116/4885RAB9A 4445/4885NPC1 604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.